Active, Not Recruiting
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
NCT06653842
- Conditions
- Cutaneous Venous Malformations
- Locations
-
- Children's Hospital of Orange County Irvine, California, United States
- Stanford University Palo Alto, California, United States
- Colorado Children's Hospital Aurora, Colorado, United States
- Johns Hopkins Baltimore, Maryland, United States